View original post on Sleep Review
The new collaboration integrates EnsoData’s FDA-cleared AI software with Nonin’s wearable pulse oximeter for at-home sleep apnea testing.
Summary
EnsoData and Nonin have announced a partnership to offer sleep labs a new home sleep apnea testing solution by combining EnsoData’s AI-powered EnsoSleep PPG software with Nonin’s WristOx2 Model 3150 pulse oximeter. This collaboration aims to enhance the accuracy and accessibility of sleep apnea diagnosis, particularly for underserved populations, by offering sleep labs an affordable, FDA-cleared solution for at-home testing.
Key Takeaways
- Partnership: EnsoData’s AI-driven EnsoSleep PPG software will be integrated with Nonin’s WristOx2 Model 3150 pulse oximeter, creating a solution for home-based sleep apnea testing.
- FDA-Cleared Technology: The partnership leverages the recently FDA-cleared EnsoSleep PPG software and Nonin’s pulse oximetry technology.
- Improved Access to Diagnosis: This collaboration is designed to address the needs of the underserved sleep apnea population, providing sleep labs with a more accessible and cost-effective option for diagnosing sleep apnea outside of traditional clinical settings.